FR2560045B1 - Nouvelles compositions a base de composants d'acides nucleiques - Google Patents

Nouvelles compositions a base de composants d'acides nucleiques

Info

Publication number
FR2560045B1
FR2560045B1 FR8418726A FR8418726A FR2560045B1 FR 2560045 B1 FR2560045 B1 FR 2560045B1 FR 8418726 A FR8418726 A FR 8418726A FR 8418726 A FR8418726 A FR 8418726A FR 2560045 B1 FR2560045 B1 FR 2560045B1
Authority
FR
France
Prior art keywords
nucleic acid
acid components
compositions based
novel compositions
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8418726A
Other languages
English (en)
Other versions
FR2560045A1 (fr
Inventor
Shohei Ogoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2560045A1 publication Critical patent/FR2560045A1/fr
Application granted granted Critical
Publication of FR2560045B1 publication Critical patent/FR2560045B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
FR8418726A 1983-12-09 1984-12-07 Nouvelles compositions a base de composants d'acides nucleiques Expired FR2560045B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58233142A JPS60126220A (ja) 1983-12-09 1983-12-09 核酸成分組成物
JP4324216A JPH0662422B2 (ja) 1983-12-09 1992-12-03 核酸成分組成物

Publications (2)

Publication Number Publication Date
FR2560045A1 FR2560045A1 (fr) 1985-08-30
FR2560045B1 true FR2560045B1 (fr) 1988-08-19

Family

ID=26530870

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8418726A Expired FR2560045B1 (fr) 1983-12-09 1984-12-07 Nouvelles compositions a base de composants d'acides nucleiques

Country Status (9)

Country Link
US (1) US4758553A (fr)
EP (1) EP0149775B1 (fr)
JP (2) JPS60126220A (fr)
CA (1) CA1258632A (fr)
CH (1) CH671497A5 (fr)
DK (1) DK166601B1 (fr)
FR (1) FR2560045B1 (fr)
GB (1) GB2152814B (fr)
IT (1) IT1180633B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049372A (en) * 1982-07-13 1991-09-17 Eliezer Rapaport Anticancer activities in a host by increasing blood and plasma adenosine 5'-triphosphate (ATP) levels
JPS6117516A (ja) * 1984-07-04 1986-01-25 Morishita Seiyaku Kk ヌクレオシド含有輸液
JPH0669953B2 (ja) * 1985-08-16 1994-09-07 日産化学工業株式会社 脳脊髄系神経栄養剤
EP0355131B1 (fr) * 1987-10-28 1996-09-04 Pro-Neuron, Inc. Derives de desoxyribonucleosides d'acyle et leurs utilisations
US6348451B1 (en) 1987-10-28 2002-02-19 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
US6020322A (en) 1993-11-09 2000-02-01 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US6743782B1 (en) * 1987-10-28 2004-06-01 Wellstat Therapeutics Corporation Acyl deoxyribonucleoside derivatives and uses thereof
US6919320B1 (en) 1987-10-28 2005-07-19 Wellstat Therapeutics Corporation Pharmaceutical compositions containing deoxyribonucleosides for wound healing
US5268365A (en) * 1988-03-11 1993-12-07 Rudolph Frederick B Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
SU1575359A1 (ru) * 1988-06-14 1991-05-15 Институт Морфологии Человека Амн Ссср Способ получени рибонуклеотидов
FR2634374B1 (fr) * 1988-07-19 1993-10-15 Laboratoires Serobiologiques Agents photoprotecteurs, cytophotoprotecteurs cutanes ayant une activite photoprotectrice des cellules constitutives, fonctionnelles de la peau, en particulier des cellules de langerhans, a base de composes nucleiques : nucleoprotides, ribonucleotides et desoxyribonucleotides, ribonucleosides et desoxyribonucleosides, compositions cosmetiques ou dermo-pharmaceutiques contenant un tel agent ainsi que des nouveaux composes en soi
US7169765B1 (en) 1988-10-27 2007-01-30 Wellstat Therapeutics Corporation Acyl deoxyribonucleoside derivatives and uses thereof
US5231085A (en) * 1988-10-31 1993-07-27 Sandoz Ltd. Compositions and methods for the enhancement of host defense mechanisms
DE58902899D1 (de) * 1988-12-14 1993-01-14 Ciba Geigy Ag 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
JPH02204489A (ja) * 1989-02-02 1990-08-14 Ajinomoto Co Inc 易溶性２’，３’―ジデオキシイノシン、その製造法及び２’，３’―ジデオキシイノシン水性溶液の製造法
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
DE4102240C1 (fr) * 1991-01-24 1992-04-09 Birkmayer, Joerg, Univ.-Prof. Ddr., Wien, At
US5320846A (en) * 1991-04-17 1994-06-14 New England Deaconess Hospital Corp. Method and composition for testing patients with metabolic depleting diseases
US5292498A (en) * 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
USH1637H (en) * 1991-09-18 1997-03-04 Offord; Bruce W. Laser-assisted fabrication of bipolar transistors in silicon-on-sapphire (SOS)
US5264220A (en) * 1991-11-12 1993-11-23 Long David M Jr Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
JP3173844B2 (ja) * 1992-03-03 2001-06-04 雪印乳業株式会社 生体組織内ω３系脂肪酸増加剤及びそれを含む栄養組成物
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
AU713021B2 (en) * 1992-10-09 1999-11-18 University Of North Carolina At Chapel Hill, The Method of treating lung disease with uridine triphosphates
US5422343A (en) * 1992-12-21 1995-06-06 Otsuka Pharmaceutical Factory, Inc. Prophylactic and therapeutic composition for MRSA infection
US5852000A (en) * 1993-08-25 1998-12-22 Otsuka Pharmaceutical Factory, Inc. Cardiac rehabilitation agent
US5488039A (en) * 1994-01-10 1996-01-30 Abbott Laboratories Method for the production of an enteral formula containing ribo-nucleotides
US5700590A (en) * 1994-01-10 1997-12-23 Abbott Laboratories Nutritional formula with ribo-nucleotides
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
US5492899A (en) * 1994-01-10 1996-02-20 Abbott Laboratories Infant nutritional formula with ribo-nucleotides
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US20030026782A1 (en) * 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US5968913A (en) * 1996-07-03 1999-10-19 Inspire Pharmaceuticals, Inc. Pharmaceutical compositions of uridine triphosphate
IL141160A0 (en) * 1998-07-31 2002-02-10 Hme Entpr Llc A pharmaceutical composition containing a precursor of uric acid
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
WO2001026481A1 (fr) * 1999-10-13 2001-04-19 Ewos Limited Aliments pour poisson avec teneur accrue en nucleotides
AU2001227889A1 (en) * 2000-01-14 2001-07-24 The United States of America, represented by The Secretary, Department of Health & Human Services Oligodeoxynucleotide and its use to induce an immune response
WO2002069964A1 (fr) * 2001-03-05 2002-09-12 Ernest Stephen P Formulation enterale
US7666674B2 (en) 2001-07-27 2010-02-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
WO2003020884A2 (fr) 2001-08-14 2003-03-13 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Procede de generation rapide de cellules dentritique matures
WO2003054161A2 (fr) * 2001-12-20 2003-07-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Utilisation d'oligodeoxynucleotides cpg en vue d'induire l'angiogenese
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
US7345028B1 (en) * 2002-06-14 2008-03-18 Youssef Nazih R Energy-protective composition comprising adenosine phosphates
US6916795B1 (en) * 2002-06-14 2005-07-12 N.R. Youssef, Llc Energy-protective composition comprising adenosine phosphates
US8263091B2 (en) * 2002-09-18 2012-09-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
EP1908492A4 (fr) * 2005-06-22 2008-12-10 Ajinomoto Kk Activateur du récepteur métabotropique du glutamate
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
CN102481009A (zh) * 2009-08-13 2012-05-30 雀巢产品技术援助有限公司 包含外源性核苷酸的营养组合物
CN112340649B (zh) * 2020-11-04 2022-06-17 湖南长乐建材有限公司 一种移动式液压举升油管枕

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786051A (en) * 1952-04-18 1957-03-19 American Home Prod Growth-promoting substances and their recovery
US3231385A (en) * 1960-12-29 1966-01-25 Takeda Chemical Industries Ltd Dairy products
DE1692496A1 (de) * 1965-01-27 1971-08-05 Takeda Chemical Industries Ltd Futtermittel

Also Published As

Publication number Publication date
DK585684D0 (da) 1984-12-07
CA1258632A (fr) 1989-08-22
FR2560045A1 (fr) 1985-08-30
JPH0534337B2 (fr) 1993-05-21
GB8430577D0 (en) 1985-01-09
CH671497A5 (fr) 1989-09-15
US4758553A (en) 1988-07-19
JPS60126220A (ja) 1985-07-05
JPH05320052A (ja) 1993-12-03
GB2152814A (en) 1985-08-14
DK166601B1 (da) 1993-06-21
EP0149775B1 (fr) 1990-02-21
IT1180633B (it) 1987-09-23
EP0149775A1 (fr) 1985-07-31
IT8405242A0 (it) 1984-12-07
GB2152814B (en) 1987-12-09
JPH0662422B2 (ja) 1994-08-17
DK585684A (da) 1985-06-10

Similar Documents

Publication Publication Date Title
FR2560045B1 (fr) Nouvelles compositions a base de composants d'acides nucleiques
IT1172324B (it) Composizioni galeniche a base di calcitonina
FI833229A (fi) 20-aminomakrolidderivat
BE890553A (fr) Compositions a base de cyano-acrylates stabilisees
DK319885A (da) Aminophenolforbindelser
IT8249295A0 (it) Composti di 1,4-diidropiridina
DE3372366D1 (de) N-arylsulfonyl-n'-triazolyl urea
OA08269A (fr) Compositions stables à base d'interféron-gamma
IT8519640A0 (it) Dispositivo di raffreddamento
DE3563757D1 (de) Support d'enroulements
DE3565983D1 (de) N-arylsulfonyl-n'-triazinyl- and -pyrimidinyl ureas
IT1165455B (it) Composizioni polimeriche a base di policaprolattame
FR2559967B1 (fr) Cale d'encoche biaise
DK607785A (da) Allylaminer
IT8322427A0 (it) Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.
FR2577158B3 (fr) Servante d'atelier
IT8420570A1 (it) "Composizioni deodorate a base di composti organotiofosforati"
LV5402A3 (lv) Kardioprotektors "Mildonats"
FR2607513B1 (fr) Vernis d'art
FI834384A0 (fi) Framstaellningsfoerfarande foer 4(5)-acetyl-2-metylimidazol
MA20618A1 (fr) Variete clementinier precoce "ripetri"
KR860001399U (ko) 교 반 기
RO88714A2 (fr) Base d'onguent
RO94121A2 (fr) Composition stabilisatrice emulsionable en base d'alkylarylphenols
IT8423116A1 (it) Composizioni a base di poliammidi autoestinguenti